HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeted therapies: Lapatinib is effective in patients with p95HER2-positive tumors.

AuthorsLisa Hutchinson
JournalNature reviews. Clinical oncology (Nat Rev Clin Oncol) Vol. 7 Issue 7 Pg. 358 (Jul 2010) ISSN: 1759-4782 [Electronic] England
PMID20614563 (Publication Type: Comment, Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: